Tumor-Derived Microvesicles Promote Kidney Regeneration and Cytoprotective Immunomodulation

Area of Science:

• Regenerative Medicine
• Immunology
• Nephrology

Background:

• Extracellular microvesicles (MVs) are investigated for their role in tissue repair.
• Tumor-derived MVs (T-MVs) and mesenchymal stem cell-derived MVs (MSC-MVs) are potential therapeutic agents.
• Chronic kidney injury (CKI) presents a significant challenge in regenerative medicine.

Purpose of the Study:

• To compare the kidney regeneration potential of T-MVs and MSC-MVs.
• To evaluate the immunomodulatory effects of MVs in a CKI model.
• To assess the impact of MVs on kidney function and structure.

Main Methods:

• MVs were isolated from L929 sarcoma, LLC, B16 melanoma cells, and MSCs.
• A murine model of chronic kidney injury (CKI) was utilized for MVs evaluation.
• Kidney function, histology, and immune cell populations were analyzed post-treatment.

Main Results:

• Both T-MVs and MSC-MVs significantly improved kidney function and histological structure.
• MV treatment normalized collecting tubule height in the renal medulla.
• MVs reduced pro-inflammatory T cells and increased regulatory T cells in CKI mice.

Conclusions:

• T-MVs exhibit universal kidney tissue regeneration capabilities, similar to MSC-MVs.
• Both T-MVs and MSC-MVs possess anti-inflammatory and immunomodulatory effects.
• These findings highlight the therapeutic potential of MVs in kidney regeneration.